Combining COVID-19 and Seasonal Influenza Vaccines Together to Increase the Acceptance of Newly Developed Vaccines in the Eastern Mediterranean Region: a Cross-sectional Study

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2023 Nov 29

PMID 38019773

Authors

Mohamed Fakhry Hussein

Abdelhamid Elshabrawy

Sarah Assem Ibrahim

Suzan Abdel-Rahman

Hoda Ali Ahmed Shiba

Ehab Elrewany

Mohammad Haroon Hairan

Ramy Mohamed Ghazy

Affiliations

Soon will be listed here.

Abstract

Background And Aim: The World Health Organization (WHO) recommended the concomitant administration (co-administration) of inactivated seasonal influenza and coronavirus disease 2019 (COVID-19) vaccines, encouraging the practice for the 2021-2022 flu season. This study aimed to assess the acceptance of simultaneously receiving the seasonal influenza vaccine (SIV) and the COVID-19 vaccine in a single administration to reduce vaccine rejection towards the COVID-19 vaccination.

Methods: An online-based cross-section survey was conducted from 1 September to 9 November 2022, in the Eastern Mediterranean Region (EMR) through distributing the survey on different social media platforms, including Facebook, Twitter, LinkedIn and WhatsApp. We used the multi-level model to assess the variation of vaccine countries across EMR countries.

Results: In total, 3300 participants were included in this survey from 11 countries distributed in the EMR. More than one-third (40.7%) were aged 18-25 years, 60.6% were females, 54.0% had a university degree, 43.1% had previous COVID-19, and 41.9% had relatives or friends who died from COVID-19. In total, 43.3% accepted this combination because it is less costly (9%), safer (18%), more effective (17%), and has fewer doses (19%). Rejection of this combination was due to fear of side effects (31%), and no studies have been published on their effects (31%). There was a significant difference across countries, which accounted for 6% of the variance in the log-odds of accepting the combined vaccination. Multi-level analysis revealed that being male, African and losing a family member or friend from COVID-19 increased the acceptance of the theoretical combined vaccines. Additionally, the number of doses taken of the COVID-19 and influenza vaccines separately significantly affected the combined vaccine acceptance. However, previous COVID-19 infection and older age reduced the odds of accepting the combined vaccines. Occupational level, social status and educational level didn't significantly affect the acceptance odds.

Conclusions: We can conclude that combining SIV and COVID-19 vaccines in one shot increased the overall acceptance of COVID-19 vaccines among vaccine rejectors.

Citing Articles

Development and validation of an Arabic tool for assessment of post-vaccination confidence in COVID-19 vaccines (ARAB-VAX-CONF).

Abuyadek R, Abd ElHafeez S, Tahoun M, Othman S, Omran A, Fathy N J Egypt Public Health Assoc. 2024; 99(1):28.

PMID: 39551890 PMC: 11570568. DOI: 10.1186/s42506-024-00174-8.

Simultaneous vaccination against seasonal influenza and COVID-19 among the target population in Italy.

Sansone V, Miraglia Del Giudice G, Della Polla G, Angelillo I Front Public Health. 2024; 12:1431963.

PMID: 39165775 PMC: 11333221. DOI: 10.3389/fpubh.2024.1431963.

References

Ghazy R, Ibrahim S, Taha S, Elshabrawy A, Elkhadry S, Abdel-Rahman S . Attitudes of parents towards influenza vaccine in the Eastern Mediterranean Region: A multilevel analysis. Vaccine. 2023; 41(36):5253-5264. DOI: 10.1016/j.vaccine.2023.07.005. View

Atrooz F, Majd Z, Alrousan G, Zeidat S, Abuelezam N, Abughosh S . Acceptance of COVID-19 vaccination in a sample of Middle Eastern and North African (MENA) Houston residents. PLOS Glob Public Health. 2023; 3(2):e0001441. PMC: 10021233. DOI: 10.1371/journal.pgph.0001441. View

Lin X, Zhang M, Chen Y, Xue J, Chen H, Tung T . Relationship between knowledge, attitudes, and practices and COVID-19 vaccine hesitancy: A cross-sectional study in Taizhou, China. Front Med (Lausanne). 2022; 9:770933. PMC: 9445127. DOI: 10.3389/fmed.2022.770933. View

Bonanni P, Boccalini S, Bechini A, Varone O, Matteo G, Sandri F . Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. Hum Vaccin Immunother. 2019; 16(6):1313-1321. PMC: 7482742. DOI: 10.1080/21645515.2019.1688032. View

Focosi D . From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses. Vaccines (Basel). 2023; 11(1). PMC: 9860680. DOI: 10.3390/vaccines11010109. View

MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View

Elbarazi I, Yacoub M, Reyad O, Abdou M, Elhadi Y, Kheirallah K . Exploring enablers and barriers toward COVID-19 vaccine acceptance among Arabs: A qualitative study. Int J Disaster Risk Reduct. 2022; 82:103304. PMC: 9519527. DOI: 10.1016/j.ijdrr.2022.103304. View

Al Awaidi S, Abusrewil S, AbuHasan M, Akcay M, Aksakal F, Bashir U . Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN). J Infect Public Health. 2018; 11(6):845-850. PMC: 7102733. DOI: 10.1016/j.jiph.2018.07.003. View

Lennon R, Block Jr R, Schneider E, Zephrin L, Shah A . Underserved population acceptance of combination influenza-COVID-19 booster vaccines. Vaccine. 2021; 40(4):562-567. PMC: 8650809. DOI: 10.1016/j.vaccine.2021.11.097. View

10.

Palache A, Oriol-Mathieu V, Abelin A, Music T . Seasonal influenza vaccine dose distribution in 157 countries (2004-2011). Vaccine. 2014; 32(48):6369-76. DOI: 10.1016/j.vaccine.2014.07.012. View

11.

Tzenios N, Tazanios M, Chahine M . Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2023; 11(1). PMC: 9860577. DOI: 10.3390/vaccines11010016. View

12.

Santibanez T, Srivastav A, Zhai Y, Singleton J . Trends in Childhood Influenza Vaccination Coverage, United States, 2012-2019. Public Health Rep. 2020; 135(5):640-649. PMC: 7485062. DOI: 10.1177/0033354920944867. View

13.

Domnich A, Grassi R, Fallani E, Ciccone R, Bruzzone B, Panatto D . Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey. J Pers Med. 2022; 12(2). PMC: 8878648. DOI: 10.3390/jpm12020139. View

14.

Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M . COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021; 27(8):1385-1394. PMC: 8363502. DOI: 10.1038/s41591-021-01454-y. View

15.

Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer A, Daubenberger C . Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med. 2020; . DOI: 10.1136/bmjebm-2020-111549. View

16.

Abdelmoneim S, Sallam M, Hafez D, Elrewany E, Mousli H, Hammad E . COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022; 7(10). PMC: 9611447. DOI: 10.3390/tropicalmed7100298. View

17.

Dadras O, SeyedAlinaghi S, Karimi A, Shamsabadi A, Mahdiabadi S, Mohammadi P . Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎. Hum Vaccin Immunother. 2022; 18(5):2043719. PMC: 9196809. DOI: 10.1080/21645515.2022.2043719. View

18.

Al Awaidy S, Ghazy R, Mahomed O, Wesonga R . Editorial: The impact of non-pharmaceutical interventions (NPIs) on communicable diseases. Front Public Health. 2023; 11:1270709. PMC: 10484578. DOI: 10.3389/fpubh.2023.1270709. View

19.

Moriyama M, Hugentobler W, Iwasaki A . Seasonality of Respiratory Viral Infections. Annu Rev Virol. 2020; 7(1):83-101. DOI: 10.1146/annurev-virology-012420-022445. View

20.

Ghazy R, Sallam M, Abdullah F, Hussein M, Hussein M . The Effect of Combining the COVID-19 Vaccine with the Seasonal Influenza Vaccine on Reducing COVID-19 Vaccine Rejection Among Libyans. J Epidemiol Glob Health. 2023; 13(2):292-302. PMC: 10176301. DOI: 10.1007/s44197-023-00107-2. View